Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: J Rheumatol. 2022 Mar 15;49(7):672–679. doi: 10.3899/jrheum.211242

Table 3:

Associations of RA-related autoantibodies with isolated RA-bronchiectasis

RA-related autoantibody
status*
MultivariableOR for
isolated RA-BR (95%CI)
p-value
RF negative 1.00 (Ref)
RF positive (>1x ULN) 4.40 (2.14-9.07) <0.0001
 
RF negative 1.00 (Ref)
RF low-positive (>1-3x ULN) 1.95 (0.67-5.66) 0.22
RF high-positive (>3x ULN) 5.44 (2.57-11.54) <0.0001
 
Anti-CCP negative 1.00 (Ref)
CCP positive (>1x ULN) 3.47 (1.65-7.31) 0.001
 
Anti-CCP negative 1.00 (Ref)
Anti-CCP low-positive (>1-3x ULN) 1.45 (0.29-7.32) 0.65
Anti-CCP high-positive (>3x ULN) 3.73 (1.76-7.90) 0.0006
*

RF analyses included 53 cases and 352 controls (n=12 missing RF status); anti-CCP analyses included 44 cases and 320 controls (n=53 missing anti-CCP status)

Adjusted for age, sex, race, RA duration, smoking status, pack-years, and body mass index anti-CCP = anti-cyclic citrullinated peptide; BR = bronchiectasis; CI = confidence interval; OR = odds ratio; RA = rheumatoid arthritis; RF = rheumatoid factor; ULN = upper limit of normal